Morgan Stanley reiterates Equalweight rating on CoreWeave stock

CoreWeave (CRWV) posted strong Q2 2025 revenue of $1.21 billion, exceeding consensus on robust GPU demand and key contracts, though EPS missed expectations at -$0.6. Despite the stock's 272% six-month surge, Morgan Stanley maintained an Equalweight rating and a $91 price target, highlighting significant customer concentration risk from large clients like Microsoft and OpenAI, which it views as a "double-edged sword" despite driving unprecedented top-line growth. This stance, coupled with varied analyst ratings ranging from Hold to Underperform citing profitability concerns, underscores investor debate on the sustainability of CoreWeave's rapid expansion and its current high valuation.

Analysis

CoreWeave (CRWV) reported paradoxical second-quarter 2025 results, showcasing a significant revenue beat at $1.21 billion against a $1.08 billion consensus, driven by strong compute demand and major contracts with clients like Microsoft and OpenAI. However, this top-line strength was offset by a notable earnings miss, with an EPS of -$0.6 versus an expected -$0.2. This performance underscores the central conflict facing the company: while large contracts validate its position in the GPU build-out market and enable massive scaling, they also create what Morgan Stanley terms a "double-edged sword" of significant customer concentration risk. Despite the stock's 272% surge over the past six months to $148.75, analyst sentiment remains mixed and cautious. Morgan Stanley maintains an Equalweight rating with a $91 price target, awaiting evidence of a broader customer base to build confidence in growth durability. This caution is echoed by other firms, with DA Davidson citing "deteriorating profitability and increased borrowing costs" in its Underperform rating, reflecting a broader market debate on whether the company's valuation has outpaced its fundamental stability and path to profitability.

Key Decisions for Investors

• Investors should closely monitor future announcements for evidence of customer base diversification, as reliance on a few large contracts is a primary risk factor highlighted by analysts.
• Given the stock's 272% run-up and the recent earnings per share miss, it is critical to scrutinize upcoming financial reports for a clear and sustainable path to profitability that can justify the current high valuation.
• The wide divergence in analyst ratings, from Underperform to Equalweight with price targets well below the current market price, warrants a cautious approach, weighing the long-term potential of the GPU economy against near-term profitability and concentration risks.